Categories: HealthcareNews

Hologic to Webcast Presentation at the Morgan Stanley 22nd Annual Global Healthcare Conference    

MARLBOROUGH, Mass.–(BUSINESS WIRE)–$HOLX #holx–Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Thursday, September 5th, at 12:20 p.m. Eastern Time.


The fire-side chat presentation will be webcast live and may be accessed through a link on the investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

SOURCE: Hologic, Inc.

Contacts

Paula Izidoro

Manager, Investor Relations and Social Media

(858) 410-8904

paula.izidoro@hologic.com

Staff

Recent Posts

Hemostemix CEO Introduces Conformal Consciousness Hypothesis A = E/(hv)

Thomas Smeenk, BA, unveils a proposed conformal invariant, A = E/(hv), explored as a potential…

2 hours ago

HPN Holdings, Inc. Executes Letter of Intent to Merge with Innovative Nonstandard Auto Insurance Provider Orange Insurance

HPN Holdings and Orange Insurance Merger Signals the Future of Nonstandard Auto Insurance With AI…

2 hours ago

Hemostemix Grants Stock Options

Calgary, Alberta--(Newsfile Corp. - December 11, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

3 hours ago

BetterLife Pharma Announces Engagement with Shanghai-Based YAFO Capital

Vancouver, British Columbia--(Newsfile Corp. - December 11, 2025) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE:…

3 hours ago

CASI Pharmaceuticals Announces Up to $20 Million Convertible Note Financing

- Investment to Fund Phase 1 Study in Renal Allograft Antibody-Mediated Rejection (AMR) in China…

3 hours ago